|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3,205 JPY | +0.47% |
|
+1.26% | -1.99% |
| Apr. 25 | Hidehiro Imatsu named president of Goldman Sachs Japan | RE |
| Mar. 21 | Tranche Update on Mochida Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on May 15, 2023. | CI |
Mochida Pharmaceutical Co., Ltd. reported earnings results for the full year ended March 31, 2023. For the full year, the company reported sales was JPY 103,261 million. Net income was JPY 6,649 million.
Basic earnings per share from continuing operations was JPY 178.93.
| 1st Jan change | Capi. | |
|---|---|---|
| -1.99% | 719M | |
| +33.25% | 704B | |
| +28.59% | 577B | |
| -3.55% | 348B | |
| +18.16% | 327B | |
| +4.36% | 288B | |
| +14.81% | 234B | |
| +4.93% | 198B | |
| -9.78% | 194B | |
| -3.69% | 147B |
MOCHIDA PHARMACEUTICAL CO., LTD. 
